Početna › Dermatomiozitis › Kalifornija
Kliničke studije za Dermatomiozitis u državi Kalifornija
9 studija za Dermatomiozitis traži sudionike na lokacijama u državi Kalifornija.
Službeni tekst studije (engleski)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Irvine
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of California Irvine - Accepting Adult Patients, Orange
- University of California, San Francisco Benioff Children's Hospital - Accepting Young Adult and Juvenile Patients, San Francisco
U tijeku regrutacijaFaza 2/3
Od 6 do 75 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT06154252A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, La Jolla
- Research Site, Sacramento
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT06916806A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- 200 UCLA Medical Plaza, Los Angeles
- UCLA Clinical & Translational Research Center (CTRC), Los Angeles
- UCLA, Los Angeles
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
U tijeku regrutacijaFaza 1
Od 18 do 74 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT07085104FT839 in Autoimmune Diseases
- Providence Medical Foundation, Fullerton
U tijeku regrutacijaFaza 1/2
Od 18 do 70 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07800871Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of California-Irvine, Orange
U tijeku regrutacijaFaza 1
Od 18 do 85 godina · Oba spola · Ažurirano 22. srp 2026. · NCT06371417Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
- Stanford University, Palo Alto
- Stanford University, Stanford
U tijeku regrutacijaFaza 1
Od 25 do 72 godina · Oba spola · Ažurirano 21. svi 2025. · NCT06298019Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.